Cytomx Therapeutics Inc (CTMX) 財務データ
*すべての数値は百万単位です
| 期間終了日 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|---|
| 期間の長さ | 3 か月 | 3 か月 | 3 か月 | 3 か月 | 3 か月 |
| Revenues | 19.04%1.69 | 1.42 | 10.26 | 0.66 | 5.96 |
0.04%25.19 | 25.20 | 29.93 | 28.60 | 21.73 | |
| Research and Development | 6.35%16.48 | 17.60 | 19.24 | 21.24 | 15.30 |
| Operating Income/Loss | 1.17%-23.50 | -23.78 | -19.67 | -27.93 | -15.77 |
| Income/Loss From Continuing Operations Before Tax | 3.25%-19.94 | -20.61 | -18.19 | -26.46 | -14.17 |
| Income Tax Expense/Benefit | 1.67%0.06 | 0.06 | 0.06 | 0.05 | 0.06 |
3.23%-20.00 | -20.67 | -18.25 | -26.51 | -14.23 | |
| Attributable To Parent | 3.23%-20.00 | -20.67 | -18.25 | -26.51 | -14.23 |
| Available To Common Stockholders, Basic | 3.23%-20.00 | -20.67 | -18.25 | - | -14.23 |
| Basic Average Shares | 0.08%219.11 | 218.94 | 177.27 | - | 165.00 |
| Diluted Average Shares | 0.08%219.11 | 218.94 | 177.27 | - | 165.00 |